GAMMA Investing »

Candel Therapeutics shares owned by GAMMA Investing

Quarter-by-quarter ownership of Candel Therapeutics (CADL) shares owned by GAMMA Investing from 13F filings

Historical chart of GAMMA Investing investment in Candel Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Candel Therapeutics held by GAMMA Investing consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Candel Therapeutics by GAMMA Investing

Quarter filed Position value Share count Share price at filing
2024-09-30 $200 29 6.93

More positions owned by GAMMA Investing

Apple Common Stock (AAPL)
Microsoft Corp Common Stock (MSFT)
Nvidia Corporation Common Stock (NVDA)
Amazon Common Stock (AMZN)
Meta Platforms Inc Cl A Common Stock (META)
Jpmorgan Chase Common Stock (JPM)
Broadcom Common Stock (AVGO)
Alphabet Inc Cap Stk Cl A Common Stock (GOOGL)
Eli Lilly Common Stock (LLY)
Ishares Inc Core Msci Emkt Etf (IEMG)
Alphabet Inc Cap Stk Cl C Common Stock (GOOG)
Ishares Tr National Mun Etf Etf (MUB)
Berkshire Hathaway Inc Del Cl B Common Stock (BRK.B)
Visa Inc Com Cl A Common Stock (V)
Home Depot Common Stock (HD)

View all positions for GAMMA Investing

Top funds holding Candel Therapeutics

Northpond Ventures
BlackRock
BlackRock
Vanguard Group
State Street Corporation
Geode Capital Management
Sands Capital Ventures
Nuveen Asset Management
Susquehanna International
Northern Trust
Citadel Advisors
Bridgeway Capital Management
Jane Street
HB Wealth Management
Charles Schwab Investment Management

View all funds holding Candel Therapeutics